Global Alliance Formed to Expand Access to Personalized Cancer Testing

Salt Lake City, Monday, 20 July 2026.
Burning Rock and Myriad Genetics have partnered to expand advanced genomic testing globally, introducing new tools to precisely evaluate prostate cancer and guide personalized treatment decisions.